140 related articles for article (PubMed ID: 35849790)
1. Clinical Outcomes and Risk Stratification of Early-Stage Melanoma Micrometastases From an International Multicenter Study: Implications for the Management of American Joint Committee on Cancer IIIA Disease.
Moncrieff MD; Lo SN; Scolyer RA; Heaton MJ; Nobes JP; Snelling AP; Carr MJ; Nessim C; Wade R; Peach AH; Kisyova R; Mason J; Wilson ED; Nolan G; Pritchard Jones R; Johansson I; Olofsson Bagge R; Wright LJ; Patel NG; Sondak VK; Thompson JF; Zager JS
J Clin Oncol; 2022 Dec; 40(34):3940-3951. PubMed ID: 35849790
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Indications for Sentinel Node Biopsy in Early-Stage Melanoma with the Advent of Adjuvant Systemic Therapy: An International, Multicenter Study.
Moncrieff MD; Lo SN; Scolyer RA; Heaton MJ; Nobes JP; Snelling AP; Carr MJ; Nessim C; Wade R; Peach AH; Kisyova R; Mason J; Wilson ED; Nolan G; Pritchard Jones R; Sondak VK; Thompson JF; Zager JS
Ann Surg Oncol; 2022 Sep; 29(9):5937-5945. PubMed ID: 35562521
[TBL] [Abstract][Full Text] [Related]
3. Risk Stratification of Sentinel Node Metastasis Disease Burden and Phenotype in Stage III Melanoma Patients.
Hussain Z; Heaton MJ; Snelling AP; Nobes JP; Gray G; Garioch JJ; Moncrieff MD
Ann Surg Oncol; 2023 Mar; 30(3):1808-1819. PubMed ID: 36445500
[TBL] [Abstract][Full Text] [Related]
4. External validation of the American Joint Committee on Cancer 8th edition melanoma staging system: who needs adjuvant treatment?
Madu MF; Franke V; Van de Wiel BA; Klop WMC; Jóźwiak K; van Houdt WJ; Wouters MWJM; van Akkooi ACJ
Melanoma Res; 2020 Apr; 30(2):185-192. PubMed ID: 31651715
[TBL] [Abstract][Full Text] [Related]
5. Epidermal autophagy and beclin 1 regulator 1 and loricrin: a paradigm shift in the prognostication and stratification of the American Joint Committee on Cancer stage I melanomas.
Ellis R; Tang D; Nasr B; Greenwood A; McConnell A; Anagnostou ME; Elias M; Verykiou S; Bajwa D; Ewen T; Reynolds NJ; Barrett P; Carling E; Watson G; Armstrong J; Allen AJ; Horswell S; Labus M; Lovat PE
Br J Dermatol; 2020 Jan; 182(1):156-165. PubMed ID: 31056744
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and predictive value of AJCC-8 staging in the phase III EORTC1325/KEYNOTE-054 trial of pembrolizumab vs placebo in resected high-risk stage III melanoma.
Eggermont AMM; Blank CU; Mandala M; Long GV; Atkinson VG; Dalle S; Haydon A; Lichinitser M; Khattak A; Carlino MS; Sandhu S; Larkin J; Puig S; Ascierto PA; Rutkowski P; Schadendorf D; Koornstra R; Hernandez-Aya L; Di Giacomo AM; van den Eertwegh AJ; Grob JJ; Gutzmer R; Jamal R; Lorigan PC; Lupinacci R; Krepler C; Ibrahim N; Kicinski M; Marreaud S; van Akkooi AC; Suciu S; Robert C
Eur J Cancer; 2019 Jul; 116():148-157. PubMed ID: 31200321
[TBL] [Abstract][Full Text] [Related]
7. Stage IIIa Melanoma and Impact of Multiple Positive Lymph Nodes on Survival.
Woeste MR; McMasters KM; Egger ME
J Am Coll Surg; 2021 Apr; 232(4):517-524.e1. PubMed ID: 33316426
[TBL] [Abstract][Full Text] [Related]
8. Isolated melanoma cells in sentinel lymph node in stage IIIA melanoma correlate with a favorable prognosis similar to stage IB.
Amaral T; Nanz L; Stadler R; Berking C; Ulmer A; Forschner A; Meiwes A; Wolfsperger F; Meraz-Torres F; Chatziioannou E; Martus P; Flatz L; Garbe C; Leiter U
Eur J Cancer; 2024 Apr; 201():113912. PubMed ID: 38368742
[TBL] [Abstract][Full Text] [Related]
9. Validation of the American Joint Committee on Cancer Eighth Edition Staging of Patients With Metastatic Cutaneous Melanoma Treated With Immune Checkpoint Inhibitors.
Waninger JJ; Ma VT; Journey S; Skvarce J; Chopra Z; Tezel A; Bryant AK; Mayo C; Sun Y; Sankar K; Ramnath N; Lao C; Sussman JB; Fecher L; Alva A; Green MD
JAMA Netw Open; 2021 Mar; 4(3):e210980. PubMed ID: 33687443
[TBL] [Abstract][Full Text] [Related]
10. Risk stratification of sentinel node-positive melanoma patients defines surgical management and adjuvant therapy treatment considerations.
Verver D; van Klaveren D; van Akkooi ACJ; Rutkowski P; Powell BWEM; Robert C; Testori A; van Leeuwen BL; van der Veldt AAM; Keilholz U; Eggermont AMM; Verhoef C; Grünhagen DJ
Eur J Cancer; 2018 Jun; 96():25-33. PubMed ID: 29660597
[TBL] [Abstract][Full Text] [Related]
11. Classification of 3097 patients from the Japanese melanoma study database using the American joint committee on cancer eighth edition cancer staging system.
Fujisawa Y; Yoshikawa S; Minagawa A; Takenouchi T; Yokota K; Uchi H; Noma N; Nakamura Y; Asai J; Kato J; Fujiwara S; Fukushima S; Uehara J; Hoashi T; Kaji T; Fujimura T; Namikawa K; Yoshioka M; Murata N; Ogata D; Matsuyama K; Hatta N; Shibayama Y; Fujiyama T; Ishikawa M; Yamada D; Kishi A; Nakamura Y; Shimiauchi T; Fujii K; Fujimoto M; Ihn H; Katoh N
J Dermatol Sci; 2019 May; 94(2):284-289. PubMed ID: 31023613
[TBL] [Abstract][Full Text] [Related]
12. External validation of the American Joint Committee on Cancer melanoma staging system eighth edition using the surveillance, epidemiology, and end results program.
Tjokrowidjaja A; Browne L; Soudy H
Asia Pac J Clin Oncol; 2022 Oct; 18(5):e280-e288. PubMed ID: 34811927
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial.
Eggermont AMM; Blank CU; Mandalà M; Long GV; Atkinson VG; Dalle S; Haydon AM; Meshcheryakov A; Khattak A; Carlino MS; Sandhu S; Larkin J; Puig S; Ascierto PA; Rutkowski P; Schadendorf D; Koornstra R; Hernandez-Aya L; Di Giacomo AM; van den Eertwegh AJM; Grob JJ; Gutzmer R; Jamal R; Lorigan PC; van Akkooi ACJ; Krepler C; Ibrahim N; Marreaud S; Kicinski M; Suciu S; Robert C;
Lancet Oncol; 2021 May; 22(5):643-654. PubMed ID: 33857412
[TBL] [Abstract][Full Text] [Related]
14. International Validation of the American Joint Committee on Cancer's 7th Edition Classification of Uveal Melanoma.
AJCC Ophthalmic Oncology Task Force
JAMA Ophthalmol; 2015 Apr; 133(4):376-83. PubMed ID: 25555246
[TBL] [Abstract][Full Text] [Related]
15. Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
Gershenwald JE; Scolyer RA; Hess KR; Sondak VK; Long GV; Ross MI; Lazar AJ; Faries MB; Kirkwood JM; McArthur GA; Haydu LE; Eggermont AMM; Flaherty KT; Balch CM; Thompson JF;
CA Cancer J Clin; 2017 Nov; 67(6):472-492. PubMed ID: 29028110
[TBL] [Abstract][Full Text] [Related]
16. American Joint Committee on Cancer clinical stage as a selection criterion for sentinel lymph node biopsy in thin melanoma.
Vaquerano J; Kraybill WG; Driscoll DL; Cheney R; Kane JM
Ann Surg Oncol; 2006 Feb; 13(2):198-204. PubMed ID: 16418885
[TBL] [Abstract][Full Text] [Related]
17. Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial.
Eggermont AMM; Blank CU; Mandala M; Long GV; Atkinson VG; Dalle S; Haydon AM; Meshcheryakov A; Khattak A; Carlino MS; Sandhu S; Larkin J; Puig S; Ascierto PA; Rutkowski P; Schadendorf D; Koornstra R; Hernandez-Aya L; Di Giacomo AM; van den Eertwegh AJM; Grob JJ; Gutzmer R; Jamal R; Lorigan PC; van Akkooi ACJ; Krepler C; Ibrahim N; Marreaud S; Kicinski M; Suciu S; Robert C
J Clin Oncol; 2020 Nov; 38(33):3925-3936. PubMed ID: 32946353
[TBL] [Abstract][Full Text] [Related]
18. Melanoma-specific survival in patients with positive sentinel lymph nodes: Relevance of sentinel tumor burden.
Satzger I; Leiter U; Gräger N; Keim U; Garbe C; Gutzmer R
Eur J Cancer; 2019 Dec; 123():83-91. PubMed ID: 31677550
[TBL] [Abstract][Full Text] [Related]
19. Greater Tumor Thickness, Ulceration, and Positive Sentinel Lymph Node Are Associated With Worse Prognosis in Patients With Conjunctival Melanoma: Implications for Future AJCC Classifications.
Esmaeli B; Rubin ML; Xu S; Goepfert RP; Curry JL; Prieto VG; Ning J; Tetzlaff MT
Am J Surg Pathol; 2019 Dec; 43(12):1701-1710. PubMed ID: 31425167
[TBL] [Abstract][Full Text] [Related]
20. Predicting Recurrence-Free and Overall Survival for Patients With Stage II Melanoma: The MIA Calculator.
Varey AHR; Li I; El Sharouni MA; Simon J; Dedeilia A; Ch'ng S; Saw RPM; Spillane AJ; Shannon KF; Pennington TE; Rtshiladze M; Stretch JR; Nieweg OE; van Akkooi A; Sullivan RJ; Boland GM; Gershenwald JE; van Diest PJ; Scolyer RA; Long GV; Thompson JF; Lo SN
J Clin Oncol; 2024 Apr; 42(10):1169-1180. PubMed ID: 38315961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]